Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer

Author： Makhija S.   Sit A.   Edwards R.   Aufman K.   Weiss H.   Kanbour-Shakir A.   Gooding W.   D'Angelo G.   Ferrell R.   Raja S.   Godfrey T.E.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.90, Iss.1, 2003-07, pp. : 3-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alterations in SPARC and VEGF Immunoreactivity in Epithelial Ovarian Cancer

By Paley P.J.   Goff B.A.   Gown A.M.   Greer B.E.   Sage E.H.  

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 336-341

Elsevier

Access to resources Recommend Favorite

p53 And related proteins in epithelial ovarian cancer

By Sengupta P.S.   McGown A.T.   Bajaj V.   Blackhall F.   Swindell R.   Bromley M.   Shanks J.H.   Ward T.   Buckley C.H.   Reynolds K.   Slade R.J.   Jayson G.C.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2317-2328

Elsevier

Access to resources Recommend Favorite

Evaluation of Chemoresistance Markers in Women with Epithelial Ovarian Carcinoma

By Goff B.A.   Paley P.J.   Greer B.E.   Gown A.M.  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 18-24

Elsevier

Access to resources Recommend Favorite

Is there a genomic basis for primary chemoresistance in ovarian cancer?

By Annunziata C.M.   Kohn E.C.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers

By              

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1759-1763

Spandidos Publications

Access to resources Recommend Favorite